SEARCH

SEARCH BY CITATION

References

  • 1
    Pillai M, O'Brien K, Hill E. The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders or physical learning disabilities. BJOG 2009;117:21621.
  • 2
    Quint E. The conservative management of abnormal uterine bleeding in teenagers with developmental disabilities. J Pediatr Adolesc Gynecol 2003;16:546.
  • 3
    Burke LM, Kalpakjian CZ, Smith YR, Quint EH. Gynaecological issues of adolescents with Down syndrome, autism and cerebral palsy. J Pediatr Adolesc Gynecol 2010;23:115.
  • 4
    Dizon CD, Allen LM, Ornstein MP. Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at the hospital for sick children, Toronto. J Pediatr Adolesc Gynecol 2005;18:15762.
  • 5
    Zacharin MR. Puberty, contraception, and hormonal management for young people with disabilities. Clin Pediatr 2009;48:14956.
  • 6
    Backeljauw PF, Rose SR, Lawson M. Clinical management of menstruation in adolescent females with developmental delay. Endocrinologist 2004;14:8792.
  • 7
    van Schrojenstein Lantman-de Valk HM, Walsh PN. Managing health problems in people with intellectual disabilities. BMJ 2008;337:a2507.
  • 8
    Obaydi H, Puri BK. Prevalence of premenstrual syndrome in autism: a prospective observer-rated study. J Int Med Res 2008;36:26872.
  • 9
    Verrotti A, D'Egidio C, Coppola G, Parisi P, Chiarelli F. Epilepsy, sex hormones and antiepileptic drugs in female patients. Expert Rev Neurother 2009;12:180314.
  • 10
    Center for Disease Control. Body Mass Index: BMI for Children and Teens. [http://www.cdc.gov/nccdphp/dnpa/healthyweight/assessing/bmi/childrens_BMI/about_childrens_BMI.htm].
  • 11
    McManhon M, Huyton M, Hindley D. Management of menstruation in severe learning disability. Arch Dis Child 2008;93:1812.
  • 12
    Albanese A., Hopper NW. Suppression of menstruation in adolescents with severe learning disabilities. Arch Dis Child 2007;92:62932.
  • 13
    Zurawin RK, Paransky OI. The role of surgical techniques in the treatment of menstrual problems and as contraception in adolescents with disabilities. J Pediatr Adolesc Gynecol 2003;16:516.
  • 14
    Faculty of Sexual and Reproductive Health Care. UK Medical Eligibility Criteria for Contraceptive Use (UKMEC 2009); 2009 [http://www.fsrh.org/pdfs/UKMEC2009.pdf].
  • 15
    Lopez L, Grimes D, Gallo M, Schultz K. Skin patch and vaginal ring versus combined oral contraceptive for contraception. Cochrane Database Sys Review 2010;(3):CD003552.
  • 16
    Faculty of Sexual and Reproductive Health Clinical Effectiveness Unit Antiepileptic Drugs and Contraception (CEU Statement); 2010 [http://www.fsrh.org/pdfs/CEUStatementADC0110.pdf].
  • 17
    Harel Z, Gold MA, Hertweck P, Brown R, Bruner A, Stager M, et al. The impact of depot medroxyprogesterone acetate on adolescent bone mineral density. J Pediatr Adolesc Gynecol 2006;19:13540.
  • 18
    Faculty of Sexual and Reproductive Health Care Clinical Effectiveness Unit. Progestogen-only Implants. CEU Statement. 2008 [http://www.fsrh.org/pdfs/CEUGuidanceProgestogenOnlyImplantsApril08.pdf].
  • 19
    Bonny AE, Harkness LS, Cromer BA. Depot Medroxyprogesterone Acetate: implications for weight status and bone mineral density in the adolescent female. Adolesc Med Clin 2005;16:56985.
  • 20
    Cromer B. In favor of continued use of depot medroxyprogesterone acetate (DMPA, Depo-Provera) in Adolescents. J Pediatr Adolesc Gynecol 2005;18:1838.
  • 21
    Cromer BA, Scholes D, Berenson A, Cundy T, Clark MK, Kaunitz AM et al. Depot medroxyprogesterone acetate and bone mineral density in adolescents: the black box warning: a position paper of the Society for Adolescent Medicine. Adolesc Health. 2006;39:296301.
  • 22
    d'Arcanques D. WHO statement on hormonal contraception and bone health. Contraception. 2006;73:4434.
  • 23
    van der Sluis IM, Boot AM, Krenning EP, Drop SL, de Muinck Keizer-Schrama SM. Longitudinal follow-up on bone density and body composition in children with precocious or early puberty before, during and after cessation of GnRH agonist therapy. J Clin Endocrinol Metab 2002;87:50612.
  • 24
    Mirena physician information [www.mirena-us.com/pdf/mirena_pi.pdf].
  • 25
    Longinotti MK, Jacobson GF, Hung Y-Y, Learman LA. Probability of hysterectomy after endometrial ablation. Obstetrics & Gynaecology 2008;112:121420.
  • 26
    Butler GE, Beadle EA. Manipulating growth and puberty in those with severe disability: when is it justified? Arch Dis Child 2007;92:5678.
  • 27
    Gunther DF, Diekma DS. Attenuating growth in children with profound disability: a new approach to an old dilemma. Arch Pediatr Adolesc Med 2006;160:10137.
  • 28
    Dyer C. Mother asks surgeons to perform hysterectomy on daughter with cerebal palsy. BMJ 2007;335:743.
  • 29
    Gillon R. On sterilising severely mentally handicapped people. J Med Ethics 1987;13:5961.
  • 30
    Dyer C. Law lords give reasons for their decision on consent. BMJ 1989;298:1542.
  • 31
    Dyer C. Sterilisation of mentally handicapped adults. BMJ 1988;297:1494.
  • 32
    Ashley's blog [http://www.pillowangel.org/].
  • 33
    Hope T, Savulescu J, Hendrick J. Medical Ethics and Law: The Core Curriculum. 2nd ed. Edinburgh: Churchill Livingston; 2008.